Researchers find alcohol plays no role in disclosing HIV status among Russians

June 11, 2012

Disclosure of HIV positive serostatus to sexual partners is considered an important public health goal to prevent new infections. Disclosure can motivate sex partners to make informed choices and change behavior through negotiation of safer sex practices. It might also prompt partner testing and counseling.

A team of Boston University School of Medicine (BUSM)researchers in cooperation with Pavlov State University investigated nondisclosure of in a cohort of 700 people living with HIV in St. Petersburg, Russia. In Russia, an is currently growing at explosive rates, particularly among . Russians are also worldwide leaders in , which has led to a national health crisis, adds further to health problems and potentially facilitates the spread of HIV.

The BUSM and Pavlov team found that approximately half (52.4 percent) of all participants surveyed reported not having disclosed their HIV serostatus to all partners since they had known of their infection. The study findings, which currently appear on-line in the journal AIDS Behavior, suggest that alcohol seems to play no major role in the decision to disclose or not. However, those in a relationship with a casual partner, an HIV negative partner, or with multiple sex partners were less likely to disclose.

"We now know that nondisclosure of to sex partners is still very common in Russia and that risky alcohol use is also very common however we were there we were unable to detect an association between any alcohol use and the outcome of recent nondisclosure," explained lead author Karsten Lunze, MD, a fellow in the Clinical & Education Unit at BUSM.

According to the authors these results emphasize that Russian health care providers should find out whether their patients have casual, HIV negative, or multiple sex partners, and particularly counsel and encourage those patients to disclose their HIV diagnosis to help prevent a further spread of the dramatic HIV epidemic in Russia.

Explore further: Study finds HIV-infected men at risk for spreading HIV despite taking HAART

Related Stories

Study finds HIV-infected men at risk for spreading HIV despite taking HAART

March 27, 2012
Researchers from Boston University School of Medicine (BUSM) and Fenway Health have found that highly active antiretroviral therapy (HAART) does not completely suppress HIV in the semen of sexually active HIV-infected men ...

Fighting HIV in South Africa should focus on couples, study finds

April 25, 2011
A new study of sexual risk behaviors within long-term couples in South Africa finds that HIV-positive people take almost as much risk in their sexual behavior when they know their partner is HIV-negative or don't know their ...

Researchers find CDT biomarker ineffective for identifying unhealthy alcohol use

June 20, 2011
Researchers from Boston University School of Medicine (BUSM) have found that among HIV-infected adults with alcohol problems, measuring their carbohydrate-deficient transferrin (CDT) biomarker was a poor and inaccurate method ...

Recommended for you

Research on HIV viral load urges updates to WHO therapy guidelines

November 24, 2017
A large cohort study in South Africa has revealed that that low-level viraemia (LLV) in HIV-positive patients who are receiving antiretroviral treatment (ART) is an important risk factor for treatment failure.

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.